17.55
+10.10%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Prenetics Global
Its shares trade under the ticker PRE. It has been listed since 6 July 2021. In the fiscal year to 31 December 2025, it reported revenue of $92.4m and a net loss of $37.7m. At that date it held total assets of $203.5m and shareholders' equity of $174.6m.
Prenetics Global Ltd is a HK-based company operating in Health Care Providers & Services industry. Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The firm operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 6 Jul 2021
- Employees
- 98
- Website
- ir.prenetics.com ↗
- Head office
- 7/F, K11 ATELIER, 728 KING'S ROAD, QUARRY BAY, K3, 000000
- Incorporated in
- E9
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Sheng Wu YeungChairman of the Board, Chief Executive Officer, Co-Founder
- Dr. Chi Hung TzangCo-Founder, Chief Scientific Officer
- Mr. Hoi Chun LoChief Financial Officer
- Dr. Yung Ho WongChief Technology Officer
- Ms. Samantha KwokChief of Staff to Group Chief Executive Officer, Vice President - People and Operations
- Ms. Jordan LemerandeVice President - Product Development
- Mr. Alan ThomasVice President, Supply Chain & Operations
- Mr. Joel NeohChief Consumer Officer, Chief Executive Officer of CircleDNA
- Dr. Senthil SundaramChief Clinical Officer
- Mr. Andy CheungDirector
- Mr. Yin Pan ChengIndependent Director, since 2023
- Ms. Wing Kwan ChiuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Prenetics Global Ltd operates in the Health Care Providers & Services industry with 98 employees.
- The Diagnostics segment provides COVID-19 testing services and operates laboratories in Hong Kong.
- The Prevention segment offers genetic testing services to individuals and corporate clients in Hong Kong.
Weaknesses
- Prenetics Global Ltd has only 98 employees, which may limit operational capacity.
- The company's business is concentrated in the Health Care sector with limited diversification.
- Prenetics Global Ltd is listed on the stock market since 6 July 2021, indicating a relatively new market presence.
Opportunities
- Expanding the Diagnostics segment to include more health monitoring systems beyond COVID-19 testing.
- Growing demand for genetic testing services in the Prevention segment across Asia.
- Increasing partnerships with corporate entities for genetic testing services in Hong Kong.
Threats
- Rapid changes in health regulations affecting diagnostic testing services in Hong Kong.
- Competition from other health care providers in the Hong Kong market.
- Potential market saturation in the genetic testing segment due to increasing competitors.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.